The US Medical Imaging & Technology Alliance (MITA) is expecting to significantly strengthen its membership in the coming months by extending it to include the radiopharmaceutical industry1.
MITA will seek to represent the radiopharma sector's interests as developers, manufacturers and distributors of the medical isotopes used in nuclear medicine imaging, notably positron-emission tomography (PET)...
Please Login to read the full article.
